Back |
home / stock / galt / galt message board
Subject | By | Source | When |
---|---|---|---|
danrocks: GALT Stock is number 57 for the largest percentage gain out of 250 stocks. $GALT GALT is u | danrocks | investorshangout | 02/19/2015 4:22:55 PM |
Jake13: GALT Stock year to date has changed +10.66% percent. +7.26% in the last 30 days. $GALT Galec | Jake13 | investorshangout | 02/14/2015 11:20:03 AM |
chartguy89: GALT 3.84 Galectin Therapeutics Inc Stock Charts $GALT Last Updated: 02/13/15 Last price | chartguy89 | investorshangout | 02/14/2015 10:35:58 AM |
Emylers: GALT 3.55 Galectin Therapeutics Inc $GALT Hit a 52 week low of 3.45 Closing the day 10:42 a | Emylers | investorshangout | 12/09/2014 5:15:33 PM |
clayton: GALT 3.84 Galectin Therapeutics Inc $GALT stock added to my watch list. Right now with GALT | clayton | investorshangout | 12/08/2014 6:50:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Galectin Therapeutics Inc. Company Name:
GALT Stock Symbol:
NASDAQ Market:
Galectin Therapeutics Inc. Website:
NORCROSS, Ga., June 04, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today announced that it will attend the EASL 2024 meeting and deliver a scientific presentation. The meeting will be held June 5-8, 2024...
Fifth Data and Safety Monitoring Board (DSMB) meeting recommended the continuation, without modifications, of the Phase 2b/3 NAVIGATE study of belapectin in liver cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) NAVIGATE trial remains on track for interim top-lin...
NORCROSS, Ga., May 13, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be attending and presenting at the H.C. Wainwright 2 nd Annual BioConnect Investor Conference. Detai...